Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer’s disease

키워드

참고문헌 (145)

1. Smith RA, "Mitochondrial pharmacology", Trends Pharmacol Sci, 33, pp.341~352 (2012)
2. 유승민, "A Molecular Approach to Mitophagy and Mitochondrial Dynamics", Molecules and Cells, 41(1), pp.18~26 (2018), 한국분자세포생물학회
3. Suomalainen A, "Mitochondrial diseases : the contribution of organelle stress responses to pathology", Nat Rev Mol Cell Biol, 19, pp.77~92 (2018)
4. Leyns CEG, "TREM2deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy", Proc Natl Acad Sci U S A, 114, pp.11524~11529 (2017)
5. Corder EH, "Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families", Science, 261, pp.921~923 (1993)
6. Robert J, "Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels", Elife, 6, pp.e29595~ (2017)
7. Tai LM, "APOE-modulated Abeta-induced neuroinflammation in Alzheimer's disease : current landscape, novel data, and future perspective", J Neurochem, 133, pp.465~488 (2015)
8. Zhang B, "Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease", Cell, 153, pp.707~720 (2013)
9. Griffin WS, "Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease", Proc Natl Acad Sci U S A, 86, pp.7611~7615 (1989)
10. Eikelenboom P, "Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study", Acta Neuropathol, 57, pp.239~242 (1982)
11. Eriksen JL, "NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo", J Clin Invest, 112, pp.440~449 (2003)
12. Yan Q, "Anti-Inflammatory Drug Therapy Alters β-Amyloid Processing and Deposition in an Animal Model of Alzheimer's Disease", J Neurosci, 23, pp.7504~7509 (2003)
13. Zandi PP, "Reduced incidence of AD with NSAID but not not H2 receptor antagonists : the Cache County Study", Neurology, 59, pp.880~886 (2002)
14. Breitner JC, "Delayed onset of Alzheimer's disease with nonsteroidal antiinflammatory and histamine H2 blocking drugs", Neurobiol Aging, 16, pp.523~530 (1995)
15. Wyss-Coray T, "TGF-beta1promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice", Nat Med, 7, pp.612~618 (2001)
16. Wyss-Coray T, "Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice", Proc Natl Acad Sci U S A, 99, pp.10837~10842 (2002)
17. Liu CC, "Astrocytic LRP1Mediates Brain Abeta Clearance and Impacts Amyloid Deposition", J Neurosci, 37, pp.4023~4031 (2017)
18. Kanekiyo T, "Neuronal clearance of amyloid-beta by endocytic receptor LRP1", J Neurosci, 33, pp.19276~19283 (2013)
19. Fu Y, "ABCA7 Mediates Phagocytic Clearance of Amyloid-beta in the Brain", J Alzheimers Dis, 54, pp.569~584 (2016)
20. Chakrabarty P, "IL-10alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior", Neuron, 85, pp.519~533 (2015)
21. Grilli M, "Identification and characterization of a kappa B", Rel binding site in the regulatory region of the amyloid precursor protein gene, 1995, pp.270, 26774~26777
22. Cho HJ, "IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1", 2 signaling pathways and direct binding of STAT1to BACE1 promoter in astrocytes, 2007, pp.55, 253~262
23. Sy M, "Inflammation induced by infection potentiates tau pathological features in transgenic mice", Am J Pathol, 178, pp.2811~2822 (2011)
24. Billups B, "Presynaptic Mitochondrial Calcium Sequestration Influences Transmission at Mammalian Central Synapses", J Neurosci, 22, pp.5840~5847 (2002)
25. Zhou B, "Facilitation of axon regeneration by enhancing mitochondrial transport and rescuing energy deficits", J Cell Biol, 214, pp.103~119 (2016)
26. Tang FL, "VPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing Mitochondrial Fusion and Function", Cell Rep, 12, pp.1631~1643 (2015)
27. Johnson AB, "Nucleoside phosphatase activities associated with the tangles and plaques of alzheimer's disease : a histochemical study of natural and experimental neurofibrillary tangles", J Neuropathol Exp Neurol, 29, pp.463~478 (1970)
28. Zhang L, "Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease", Sci Rep, 6, pp.18725~ (2016)
29. Gibson GE, "Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease", Arch Neurol, 45, pp.836~840 (1988)
30. Sorbi S, "Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain", Ann Neurol, 13, pp.72~78 (1983)
31. Mutisya EM, "Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease", J Neurochem, 63, pp.2179~2184 (1994)
32. Mecocci P, "Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease", Ann Neurol, 36, pp.747~751 (1994)
33. Reddy PH, "Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer’s disease", Hum Mol Genet, 27, pp.2502~2516 (2018)
34. Devi L, "Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction", J Neurosci, 26, pp.9057~9068 (2006)
35. Lustbader JW, "ABAD Directly Links Aβ to Mitochondrial Toxicity in Alzheimer's Disease", Science, 304, pp.448~452 (2004)
36. Manczak M, "Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease", Hum Mol Genet, 21, pp.5131~5146 (2012)
37. Park J, "Loss of mitofusin 2links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells", J Neurochem, 132, pp.687~702 (2015)
38. Kim DI, "Aβ-Induced Drp1phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis", Biochim Biophys Acta, 1863, pp.2820~2834 (2016)
39. Fukui H, "Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease", Proc Natl Acad Sci U S A, 104, pp.14163~14168 (2007)
40. Krishnan KJ, "Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease", Neurobiol Aging, 33, pp.2210~2214 (2012)
41. Hoekstra JG, "Mitochondrial DNA mutations increase in early stage Alzheimer disease and are inconsistent with oxidative damage", Ann Neurol, 80, pp.301~306 (2016)
42. Coskun PE, "Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication", Proc Natl Acad Sci U S A, 101, pp.10726~10731 (2004)
43. Höglinger GU, "The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy", J Neurochem, 95, pp.930~939 (2005)
44. Lopez-Otin C, "The hallmarks of aging", Cell, 153, pp.1194~1217 (2013)
45. Scheibye-Knudsen M, "Protecting the mitochondrial powerhouse", Trends Cell Biol, 25, pp.158~170 (2015)
46. Hammerling BC, "Mitochondrial quality control in the myocardium : Cooperation between protein degradation and mitophagy", J Mol Cell Cardiol, 75, pp.122~130 (2014)
47. Cenini G, "Role of Mitochondrial Protein Quality Control in Oxidative Stress-induced Neurodegenerative Diseases", Curr Alzheimer Res, 13, pp.164~173 (2016)
48. Bragoszewski P, "Control of mitochondrial biogenesis and function by the ubiquitin-proteasome system", Open Biol, 7, pp.17007~ (2017)
49. Suliman HB, "Mitochondrial Quality Control as a Therapeutic Target", Pharmacol Rev, 68, pp.20~48 (2016)
50. Meyer A, "Mitochondria : An Organelle of Bacterial Origin Controlling Inflammation", Front Immunol, 9, pp.536~ (2018)
51. Archibald JM, "Endosymbiosis and Eukaryotic Cell Evolution", Curr Biol, 25, pp.R911~R921 (2015)
52. Barbalat R, "Nucleic acid recognition by the innate immune system", Annu Rev Immunol, 29, pp.185~214 (2011)
53. Contis A, "Neutrophil-derived mitochondrial DNA promotes receptor activator of nuclear factor kappaB and its ligand signalling in rheumatoid arthritis", Rheumatology, 56, pp.1200~1205 (2017)
54. Shimada K, "Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis", Immunity, 36, pp.401~414 (2012)
55. Bai J, "The cGAS-cGAMP-STING Pathway : A Molecular Link Between Immunity and Metabolism", Diabetes, 68, pp.1099~1108 (2019)
56. Dorward DA, "The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation", Am J Pathol, 185, pp.1172~1184 (2015)
57. Dahlgren C, "Basic characteristics of the neutrophil receptors that recognize formylated peptides, a dangerassociated molecular pattern generated by bacteria and mitochondria", Biochem Pharmacol, 114, pp.22~39 (2016)
58. Raoof M, "Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1", J Trauma, 68, pp.1328~1332 (2010)
59. Pan ZK, "fMet-Leu-Phe stimulates proinflammatory cytokine gene expression in human peripheral blood monocytes : the role of phosphatidylinositol 3-kinase", J Immunol, 164, pp.404~411 (2000)
60. Banoth B, "Mitochondria in innate immune signaling", Transl Res, 202, pp.52~68 (2018)
61. Iyer SS, "Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation", Immunity, 39, pp.311~323 (2013)
62. Chu CT, "LC3 binds externalized cardiolipin on injured mitochondria to signal mitophagy in neurons Implications for Parkinson disease", Autophagy, 10, pp.376~378 (2014)
63. Allard B, "The ectonucleotidases CD39 and CD73 : Novel checkpoint inhibitor targets", Immunol Rev, 276, pp.121~144 (2017)
64. Amores-Iniesta J, "Extracellular ATP Activates the NLRP3Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection", Cell Rep, 21, pp.3414~3426 (2017)
65. Cauwels A, "Extracellular ATP drives systemic inflammation, tissue damage and mortality", Cell Death Dis, 5, pp.e1102~e1102 (2014)
66. Eleftheriadis T, "Cytochrome c as a Potentially Clinical Useful Marker of Mitochondrial and Cellular Damage", Front Immunol, 7, pp.279~ (2016)
67. Lin ML, "Selective suicide of cross-presenting CD8(+)dendritic cells by cytochrome c injection shows functional heterogeneity within this subset", Proc Natl Acad Sci U S A, 105, pp.3029~3034 (2008)
68. Codina R, "Cytochrome c-induced lymphocyte death from the outside in : inhibition by serum leucine-rich alpha-2-glycoprotein-1", Apoptosis, 15, pp.139~152 (2010)
69. Pullerits R, "Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis", Rheumatology, 44, pp.32~39 (2005)
70. Mittal M, "Reactive Oxygen Species in Inflammation and Tissue Injury", Antioxid Redox Sign, 20, pp.1126~1167 (2014)
71. Kozlov AV, "Mitochondria-meditated pathways of organ failure upon inflammation", Redox Biol, 13, pp.170~181 (2017)
72. Naik E, "Mitochondrial reactive oxygen species drive proinflammatory cytokine production", J Exp Med, 208, pp.417~420 (2011)
73. Nakahira K, "Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome", Nat Immunol, 12, pp.222~230 (2011)
74. West AP, "Mitochondrial DNA stress primes the antiviral innate immune response", Nature, 520, pp.553~557 (2015)
75. Tian J, "Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE", Nat Immunol, 8, pp.487~496 (2007)
76. Julian MW, "Mitochondrial Transcription Factor A Serves as a Danger Signal by Augmenting Plasmacytoid Dendritic Cell Responses to DNA", J Immunol, 189, pp.433~443 (2012)
77. Jacobs JL, "Mechanisms of MAVS Regulation at the Mitochondrial Membrane", J Mol Biol, 425, pp.5009~5019 (2013)
78. Seth RB, "Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappa B and IRF3", Cell, 122, pp.669~682 (2005)
79. Subramanian N, "The Adaptor MAVS Promotes NLRP3 Mitochondrial Localization and Inflammasome Activation", Cell, 153, pp.348~361 (2013)
80. Castanier C, "Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway", EMBO Rep, 11, pp.133~138 (2010)
81. Yasukawa K, "Mitofusin 2 Inhibits Mitochondrial Antiviral Signaling", Sci Signal, 2, pp.ra47~ (2009)
82. Tang ED, "MAVS Self-Association Mediates Antiviral Innate Immune Signaling", J Virol, 83, pp.3420~3428 (2009)
83. Vogel RO, "Cytosolic signaling protein Ecsit also localizes to mitochondria where it interacts with chaperone NDUFAF1 and functions in complex I assembly", Gene Dev, 21, pp.615~624 (2007)
84. Geng J, "Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity", Nat Immunol, 16, pp.1142~1152 (2015)
85. Carneiro FRG, "An Essential Role for ECSIT in Mitochondrial Complex I Assembly and Mitophagy in Macrophages", Cell Rep, 22, pp.2654~2666 (2018)
86. Shi HX, "Mitochondrial Ubiquitin Ligase MARCH5 Promotes TLR7 Signaling by Attenuating TANK Action", PLoS Pathog, 7, pp.e1002057~ (2011)
87. Wilkins HM, "Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease : A Possible Connection", Front Aging Neurosci, 6, pp.311~ (2014)
88. Wilkins HM, "Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration", Front Immunol, 8, pp.508~ (2017)
89. Bajwa E, "The Role of Mitochondrial Damage-Associated Molecular Patterns in Chronic Neuroinflammation", Mediators Inflammation, 2019, pp.4050796~ (2019)
90. Wilkins HM, "Extracellular Mitochondria and Mitochondrial Components Act as Damage-Associated Molecular Pattern Molecules in the Mouse Brain", J Neuroimmune Pharmacol, 11, pp.622~628 (2016)
91. Guerreiro R, "TREM2variants in Alzheimer's disease", N Engl J Med, 368, pp.117~127 (2013)
92. Korvatska O, "R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family : Clinical, Genetic, and Neuropathological Study", JAMA Neurol, 72, pp.920~927 (2015)
93. Wang Y, "TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model", Cell, 160, pp.1061~1071 (2015)
94. Turnbull IR, "Cutting edge : TREM-2 attenuates macrophage activation", J Immunol, 177, pp.3520~3524 (2006)
95. Jiang T, "TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice", Neuropharmacology, 105, pp.196~206 (2016)
96. Podlesniy P, "Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease", Ann Neurol, 74, pp.655~668 (2013)
97. Thubron EB, "Regional mitochondrial DNA and cell-type changes in post-mortem brains of non-diabetic Alzheimer’s disease are not present in diabetic Alzheimer’s disease", Sci Rep, 9, pp.11386~ (2019)
98. Ruggiero FM, "Lipid composition in synaptic and nonsynaptic mitochondria from rat brains and effect of aging", J Neurochem, 59, pp.487~491 (1992)
99. Pointer CB, "Cardiolipin in Central Nervous System Physiology and Pathology", Cell Mol Neurobiol, 37, pp.1161~1172 (2017)
100. Petrosillo G, "Mitochondrial dysfunction in rat brain with aging Involvement of complex I, reactive oxygen species and cardiolipin", Neurochem Int, 53, pp.126~131 (2008)
101. Perier C, "Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage", Proc Natl Acad Sci U S A, 102, pp.19126~19131 (2005)
102. Little JP, "Mitochondrial transcription factor A(Tfam)is a proinflammatory extracellular signaling molecule recognized by brain microglia", Mol Cell Neurosci, 60, pp.88~96 (2014)
103. Schindler SM, "Pattern recognition receptors mediate pro-inflammatory effects of extracellular mitochondrial transcription factor A(TFAM)", Mol Cell Neurosci, 89, pp.71~79 (2018)
104. Julian MW, "Mitochondrial transcription factor A, an endogenous danger signal, promotes TNF release via RAGE-and TLR9-responsive plasmacytoid dendritic cells", PLoS One, 8, pp.e72354~e72354 (2013)
105. Verdier Y, "Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane : binding sites and implications for Alzheimer's disease", J Pept Sci, 10, pp.229~248 (2004)
106. Xie J, "Cellular signalling of the receptor for advanced glycation end products(RAGE)", Cell Signal, 25, pp.2185~2197 (2013)
107. Lue LF, "Involvement of microglial receptor for advanced glycation endproducts(RAGE)in Alzheimer's disease : identification of a cellular activation mechanism", Exp Neurol, 171, pp.29~45 (2001)
108. Papaliagkas V, "Prediction of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease by CSF Cytochrome c Levels and N200 Latency", Curr Alzheimer Res, 6, pp.279~284 (2009)
109. Takuma K, "Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease", J Pharmacol Sci, 97, pp.312~316 (2005)
110. Krysko DV, "Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation", Trends Immunol, 32, pp.157~164 (2011)
111. Gouveia A, "Extracellular cytochrome c as an intercellular signaling molecule regulating microglial functions", Biochim Biophys Acta Gen Subj, 1861, pp.2274~2281 (2017)
112. Oyewole AO, "Mitochondriatargeted antioxidants", FASEB J, 29, pp.4766~4771 (2015)
113. Jauslin ML, "Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants", FASEB J, 17, pp.1972~1974 (2003)
114. Gioscia-Ryan RA, "Mitochondria-targeted antioxidant(MitoQ)ameliorates age-related arterial endothelial dysfunction in mice", J Physiol, 592, pp.2549~2561 (2014)
115. Jin H, "Mitochondriatargeted antioxidants for treatment of Parkinson's disease : preclinical and clinical outcomes", Biochimica et biophysica acta, 1842, pp.1282~1294 (2014)
116. Dashdorj A, "Mitochondriatargeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasomemediated inflammatory cytokines", BMC Med, 11, pp.178~ (2013)
117. Asano T, "Possible involvement of iron-induced oxidative insults in neurodegeneration", Neurosci Lett, 588, pp.29~35 (2015)
118. Mena NP, "Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders", Mitochondrion, 21, pp.92~105 (2015)
119. Thomsen MS, "Neurodegeneration with inflammation is accompanied by accumulation of iron and ferritin in microglia and neurons", Neurobiol Dis, 81, pp.108~118 (2015)
120. Smigrodzki RM, "Mitochondrial microheteroplasmy and a theory of aging and age-related disease", Rejuvenation Res, 8, pp.172~198 (2005)
121. Casoli T, "Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer's disease neurodegeneration", Front Aging Neurosci, 7, pp.142~142 (2015)
122. Onyango IG, "Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease", Neural Regen Res, 13, pp.19~25 (2018)
123. Jo A, "Efficient Mitochondrial Genome Editing by CRISPR", Cas9, 2015, pp.2015, 305716~
124. Hashimoto M, "MitoTALEN : A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases", Mol Ther, 23, pp.1592~1599 (2015)
125. Zhong Y, "Mitochondrial transcription factor A overexpression and base excision repair deficiency in the inner ear of rats with D-galactose-induced aging", FEBS J, 278, pp.2500~2510 (2011)
126. Hayashi Y, "Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice", J Neurosci, 28, pp.8624~8634 (2008)
127. Xu S, "Overexpression of Tfam protects mitochondria against beta-amyloidinduced oxidative damage in SH-SY5Y cells", FEBS J, 276, pp.3800~3809 (2009)
128. Oka S, "Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer's disease", Sci Rep, 6, pp.37889~ (2016)
129. Heneka MT, "NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP", PS1 mice, 2013, pp.493, 674~678
130. Daniels MJ, "Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models", Nat Commun, 7, pp.12504~ (2016)
131. Dempsey C, "Inhibiting the NLRP3 inflammasome with MCC950promotes non-phlogistic clearance of amyloid-beta and cognitive function in APP", PS1 mice, 2017, pp.61, 306~316
132. Yin J, "NLRP3Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer's Disease", Mol Neurobiol, 55, pp.1977~1987 (2018)
133. Yang Y, "Recent advances in the mechanisms of NLRP3inflammasome activation and its inhibitors", Cell Death Dis, 10, pp.128~ (2019)
134. Lautrup S, "Microglial mitophagy mitigates neuroinflammation in Alzheimer's disease", Neurochem Int, 129, pp.104469~ (2019)
135. Fang EF, "Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease", Nat Neurosci, 22, pp.401~412 (2019)
136. Lei Q, "Mitochonic acid 5 activates the MAPK-ERK-yap signaling pathways to protect mouse microglial BV-2 cells against TNFalpha-induced apoptosis via increased Bnip3-related mitophagy", Cell Mol Biol Lett, 23, pp.14~ (2018)
137. Zhou R, "A role for mitochondria in NLRP3 inflammasome activation", Nature, 469, pp.221~225 (2011)
138. Jiang S, "Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex", Mol Neurodegener, 13, pp.5~ (2018)
139. Park J, "Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells", J Neurochem, 127, pp.221~232 (2013)
140. Kim H, "A mitochondrial division inhibitor, Mdivi-1, inhibits mitochondrial fragmentation and attenuates kainic acid-induced hippocampal cell death", BMC Neurosci, 17, pp.33~ (2016)
141. Joshi AU, "Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration", Nat Neurosci, 22, pp.1635~1648 (2019)
142. Akhter F, "Mitochondrial Perturbation in Alzheimer's Disease and Diabetes", Prog Mol Biol Transl Sci, 146, pp.341~361 (2017)
143. Barber GN, "STING-dependent cytosolic DNA sensing pathways", Trends Immunol, 35, pp.88~93 (2014)
144. Liang Q, "Crosstalk between the cGAS DNA sensor and Beclin-1 autophagy protein shapes innate antimicrobial immune responses", Cell Host Microbe, 15, pp.228~238 (2014)
145. Sliter DA, "Parkin and PINK1 mitigate STING-induced inflammation", Nature, 561, pp.258~262 (2018)

관련 논문AI추천